ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Rheumatology

Top Rheumatology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH LEMMER MD

Rheumatology

11,798

$1.12M

888
511 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $132

GREGORY KUJALA MD

Rheumatology

3,159

$909K

427
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$288
Average prescription price

Avg: $132

WILLIAM BLAYLOCK M.D.

Rheumatology

8,119

$898K

435
249 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

31%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $132

WALTER WALLINGFORD M.D.

Rheumatology

7,223

$790K

410
179 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $132

JANE DERRIG DO

Rheumatology

4,891

$714K

499
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$146
Average prescription price

Avg: $132

ERIC KENNY MD

Rheumatology

5,610

$705K

520
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $132

PHONG NGUYEN MD

Rheumatology

1,965

$658K

241
197 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$335
Average prescription price

Avg: $132

MICHAEL STRACHAN M.D.

Rheumatology

5,306

$633K

483
376 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $132

GARRY BAYLISS M.D.

Rheumatology

4,834

$611K

481
363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $132

ALBEN GOLDSTEIN MD

Rheumatology

6,200

$558K

236
178 are 65+

30%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $132

DON MARTIN M.D.

Rheumatology

4,071

$549K

357
253 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $132

STEWART KOHLER MD

Rheumatology

5,136

$476K

175
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $132

KATHLEEN PRICE MD

Rheumatology

1,855

$459K

142
109 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$247
Average prescription price

Avg: $132

FOLASHADE ALADE M.D.

Rheumatology

9,193

$445K

568
372 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $132

ROBERT JOHNSON M.D.

Rheumatology

3,804

$438K

393
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $132

MARGARET FISHER MD

Rheumatology

3,569

$436K

345
287 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $132

SHARUKH SHROFF MD., MPH., MBA.

Rheumatology

5,021

$431K

674
481 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $132

STEVEN MAESTRELLO M.D.

Rheumatology

4,955

$425K

500
382 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $132

JOHN PENDLETON M.D.

Rheumatology

2,131

$400K

215
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $132

PHILLIP KEMPF M. D.

Rheumatology

1,098

$399K

192
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 24%

$364
Average prescription price

Avg: $132

NEIL SULLIVAN M.D.

Rheumatology

3,380

$390K

310
226 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

33%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $132

ROGER LIDMAN M.D.

Rheumatology

1,283

$375K

226
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$292
Average prescription price

Avg: $132

JAMES SUTHERLAND M.D.

Rheumatology

3,202

$375K

378
284 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$117
Average prescription price

Avg: $132

MARY HAGERTY MD

Rheumatology

2,083

$361K

170
120 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$173
Average prescription price

Avg: $132

ELENA FLAGG M.D.

Rheumatology

2,544

$360K

323
261 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$142
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank